Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2015 1
2016 1
2017 1
2019 1
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Sex and Gender Disparities in Melanoma.
Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Carè A, Mattia G. Bellenghi M, et al. Among authors: de feo a. Cancers (Basel). 2020 Jul 7;12(7):1819. doi: 10.3390/cancers12071819. Cancers (Basel). 2020. PMID: 32645881 Free PMC article. Review.
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma.
Sciandra M, De Feo A, Parra A, Landuzzi L, Lollini PL, Manara MC, Mattia G, Pontecorvi G, Baricordi C, Guerzoni C, Bazzocchi A, Longhi A, Scotlandi K. Sciandra M, et al. Among authors: de feo a. J Cell Commun Signal. 2020 Sep;14(3):335-347. doi: 10.1007/s12079-020-00567-2. Epub 2020 Jun 5. J Cell Commun Signal. 2020. PMID: 32504411 Free PMC article.
SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B.
Bellenghi M, Puglisi R, Pedini F, De Feo A, Felicetti F, Bottero L, Sangaletti S, Errico MC, Petrini M, Gesumundo C, Denaro M, Felli N, Pasquini L, Tripodo C, Colombo MP, Carè A, Mattia G. Bellenghi M, et al. Among authors: de feo a. J Pathol. 2015 Jul;236(3):315-25. doi: 10.1002/path.4535. Epub 2015 Apr 20. J Pathol. 2015. PMID: 25802234
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity.
Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K. Balestra T, et al. Among authors: de feo a. Mol Cancer Ther. 2021 Oct 19:molcanther.0189.2021. doi: 10.1158/1535-7163.MCT-21-0189. Online ahead of print. Mol Cancer Ther. 2021. PMID: 34667115